Developability of Biopharmaceuticals

-

By accounting for developability in candidate selection, drug developers have the potential to greatly minimize costly attrition and reduce development time significantly. However, this rapidly expanding area is not without its challenges, and key issues surrounding the early implementation of molecular assessments and rational engineering approaches need to be addressed.

Developability of Biopharmaceuticals has been designed to support drug developers in reducing the cost, risk and time of development. Our agenda focuses on the opportunities such as monitoring protein thermostability to ensure optimal conditions for bioprocess and exploring new high throughput screening methods to improve confidence in candidate selection.

Location:
Revere Hotel
USA


Organizer: Hanson Wade

4 Dec 2012

UPCOMING FEATURED EVENTS 1 Next 
HPLC 201411 May 2014 Read
Neuroscience 201415 Nov 2014 Read


ALL UPCOMING EVENTS
1 2 3 Next 
European Antibody Congress 201410 Nov 2014 Read
World Biosimilar Congress 201411 Nov 2014 Read
World Orphan Drug Congress Europe 201412 Nov 2014 Read
Medica 201412 Nov 2014 Read
Neuroscience 201415 Nov 2014 Read
Translating Innovations in Diabetes Drug Development17 Nov 2014 Read
ASCB 20146 Dec 2014 Read

Write a Review

Join the Global SelectScience Community Today! It’s FREE!

Helping you make informed decisions about the latest lab products and technologies:

  • Be the first to learn about new technologies
  • 10,000+ trusted product reviews from your peers
  • Compare 500,000 products and manufacturers
  • Get exclusive buying tips from experts
  • Find solutions fast: 10,000+ Application Notes, Webinars and Videos

Connect with 250,000 scientists... All in one place!

Become a member today!